tirzepatide pulled from market FDA Says Compounded Must Exit the FDA says years-long tirzepatide shortage

Her appetite shrank, her portion sizes got smaller, and the weight loss results started to show

Naecz, D

Handling and use of these products should be restricted to suitably qualified professionals

You may still be making progress during a plateau if: Measurements are decreasing Clothing fits differently Energy levels are improving Strength is increasing Patience and consistency are often important during these periods

Close monitoring of blood glucose, especially during the first weeks of treatment and after dose increases, is essential

It is unknown whether ZEPBOUND causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans as human relevance of tirzepatide-induced rodent thyroid C-cell tumors has not been determined [see WARNINGS AND PRECAUTIONS and Nonclinical Toxicology]